ARG1 and neoplasm: M2 macrophages, referred to as TAMs from hereon, inhibit anti-tumor immune responses through multiple mechanisms, most notably, through depletion of amino acids and production of immunosuppressive metabolites, such as indolamine-2,3-dioxygenase (IDO) and arginase 1 (ARG1).